IDO1 and neoplasm: In vivo antitumor studies showed that treatment with ASPN significantly delayed the tumor growth in 4T1 tumor mice model and effectively prevented the pulmonary metastasis compared to other treatments, which was mainly owing to the synergistic antitumor effect of OXA‐induced ICD and NLG919‐mediated IDO inhibition.